HuGE Literature Finder
Records
1
-
30
| The Association of ERCC1 and ERCC5 Polymorphisms with Lung Cancer Risk in Han Chinese. Journal of Cancer 2022 1 13 (2): 517-526. Lan Xueling, Li Ying, Wu Yefeng, Li Xia, Xu L |
| Genetic polymorphisms and haplotypes of ERCC1 and ERCC2 associated with quality of life, depression, and anxiety status among patients with lung cancer. BMC cancer 2021 Jul 21 (1): 842. Tang Yunxiang, Zhang Ruike, Li Yinan, Xu Shuyu, Wang Hao, Xu Jingzhou, Xiao Lei, Wang Yajing, Du Jing, Huang Yujia, Su To |
| Genetic evaluation of the variants using MassARRAY in non-small cell lung cancer among North Indians. Scientific reports 2021 May 11 (1): 11291. Bhat Gh Rasool, Sethi Itty, Bhat Amrita, Verma Sonali, Bakshi Divya, Sharma Bhanu, Nazir Muddasser, Dar Khursheed A, Abrol Deepak, Shah Ruchi, Kumar Rake |
| Genetic polymorphisms of GSTP1, XRCC1, XPC and ERCC1: prediction of clinical outcome of platinum-based chemotherapy in advanced non-small cell lung cancer patients of Bangladesh. Molecular biology reports 2020 Sep . Bushra Most Umme, Rivu Sanzana Fareen, Sifat Ali Ehsan, Nahid Noor Ahmed, Ahmed Maizbha Uddin, Al-Mamun Mir Md Abdullah, Apu Mohd Nazmul Hasan, Islam Md Siddiqul, Islam Md Reazul, Islam Mohammad Safiqul, Hasnat Ab |
| Polymorphisms in the BER and NER pathways and their influence on survival and toxicity in never-smokers with lung cancer. Scientific reports 2020 12 10 (1): 21147. Casal-Mouriño Ana, Ruano-Ravina Alberto, Torres-Durán María, Parente-Lamelas Isaura, Provencio-Pulla Mariano, Castro-Añón Olalla, Vidal-García Iria, Abal-Arca José, Piñeiro-Lamas María, Fernández-Villar Alberto, Valdés-Cuadrado Luis, Barros-Dios Juan Miguel, Pérez-Ríos Móni |
| Promoter polymorphisms of TOP2A and ERCC1 genes as predictive factors for chemotherapy in non-small cell lung cancer patients. Cancer medicine 2019 Dec . Grenda Anna, Blach Justyna, Szczyrek Michal, Krawczyk Pawel, Nicos Marcin, Kuznar Kaminska Barbara, Jakimiec Monika, Balicka Grazyna, Chmielewska Izabela, Batura-Gabryel Halina, Sawicki Marek, Milanowski Janu |
| Residential radon, genetic polymorphisms in DNA damage and repair-related. Lung cancer (Amsterdam, Netherlands) 2019 Sep 135 10-15. Lorenzo-González María, Ruano-Ravina Alberto, Torres-Durán María, Kelsey Karl T, Provencio Mariano, Parente-Lamelas Isaura, Leiro-Fernández Virginia, Vidal-García Iria, Castro-Añón Olalla, Martínez Cristina, Golpe-Gómez Antonio, Torres-Español María, Abal-Arca José, Montero-Martínez Carmen, Fernández-Villar Alberto, Barros-Dios Juan |
| ECCR1 and NFKB2 Polymorphisms as Potential Biomarkers of Non-small Cell Lung Cancer in a Polish Population. Anticancer research 2019 Jun 39 (6): 3269-3272. Chaszczewska-Markowska Monika, Kosacka Monika, Chryplewicz Agnieszka, Dyla Tomasz, Brzecka Anna, Bogunia-Kubik Katarzy |
| Association between certain non-small cell lung cancer driver mutations and predictive markers for chemotherapy or programmed death-ligand 1 inhibition. Cancer science 2019 Apr . Liang Wenhua, Guo Minzhang, Pan Zhenkui, Cai Xiuyu, Li Caichen, Zhao Yi, Liang Hengrui, Yang Haiying, Wang Zhen, Chen Wenting, Xu Chuhong, Yang Xinyun, Sun Jianyu, He Ping, Gu Xia, Yin Weiqiang, He Jianxi |
| The Relationship Between rs3212986C>A Polymorphism and Tumor Stage in Lung Cancer Patients. Cureus 2019 Apr 11 (4): e4423. Anoushirvani Ali Arash, Aghabozorgi Reza, Ahmadi Azam, Arjomandzadegan Mohammad, Khalili Sara, Sahraei Maryam, Fereydouni Taha, Khademi Zo |
| Rs3212986 polymorphism, a possible biomarker to predict smoking-related lung cancer, alters DNA repair capacity via regulating ERCC1 expression. Cancer medicine 2018 Dec 7 (12): 6317-6330. Yu Tao, Xue Ping, Cui Su, Zhang Liang, Zhang Guopei, Xiao Mingyang, Zheng Xiao, Zhang Qianye, Cai Yuan, Jin Cuihong, Yang Jinghua, Wu Shengwen, Lu Xiao |
| Combined effect of ERCC1 and ERCC2 polymorphisms on overall survival in non-squamous non-small-cell lung cancer patients treated with first-line pemetrexed/platinum. Lung cancer (Amsterdam, Netherlands) 2018 Apr 118 90-96. Liao Wei-Yu, Ho Chao-Chi, Tsai Tzu-Hsiu, Chen Kuan-Yu, Shih Jin-Yuan, Yu Chong-J |
| Association of DNA repair gene polymorphisms with the risk of radiation pneumonitis in lung cancer patients. Oncotarget 2018 Jan 9 (1): 958-968. Du Lehui, Yu Wei, Dai Xiangkun, Zhao Nana, Huang Xiang, Tong Fang, Liu Fang, Huang Yurong, Ju Zhongjian, Yang Wei, Cong Xiaohu, Xie Chuanbin, Liu Xiaoliang, Liang Lanqing, Han Yanan, Qu Baol |
| Impact of DNA repair, folate and glutathione gene polymorphisms on risk of non small cell lung cancer. Pathology, research and practice 2017 Nov . Pérez-Ramírez Cristina, Cañadas-Garre Marisa, Alnatsha Ahmed, Villar Eduardo, Delgado Juan Ramón, Calleja-Hernández Miguel Ángel, Faus-Dáder María Jo |
| Genetic variants in ERCC1 and XPC predict survival outcome of non-small cell lung cancer patients treated with platinum-based therapy. Scientific reports 2017 Sep 7 (1): 10702. Zhang Ruoxin, Jia Ming, Xue Huijing, Xu Yuan, Wang Mengyun, Zhu Meiling, Sun Menghong, Chang Jianhua, Wei Qing |
| Genetic susceptibility variants for lung cancer: replication study and assessment as expression quantitative trait loci. Scientific reports 2017 Feb 7 42185. Pintarelli Giulia, Cotroneo Chiara Elisabetta, Noci Sara, Dugo Matteo, Galvan Antonella, Delli Carpini Simona, Citterio Lorena, Manunta Paolo, Incarbone Matteo, Tosi Davide, Santambrogio Luigi, Dragani Tommaso A, Colombo Frances |
| Evaluation of Prediction of Polymorphisms of DNA Repair Genes on the Efficacy of Platinum-Based Chemotherapy in Patients With Non-Small Cell Lung Cancer: A Network Meta-Analysis. Journal of cellular biochemistry 2017 12 118 (12): 4782-4791. Yu Shao-Nan, Liu Gui-Feng, Li Xue-Feng, Fu Bao-Hong, Dong Li-Xin, Zhang Shu-H |
| Tumor marker analyses from the phase III, placebo-controlled, FASTACT-2 study of intercalated erlotinib with gemcitabine/platinum in the first-line treatment of advanced non-small-cell lung cancer. Lung cancer (Amsterdam, Netherlands) 2016 Aug 98 1-8. Mok Tony, Ladrera Guia, Srimuninnimit Vichien, Sriuranpong Virote, Yu Chong-Jen, Thongprasert Sumitra, Sandoval-Tan Jennifer, Lee Jin Soo, Fuerte Fatima, Shames David S, Klughammer Barbara, Truman Matt, Perez-Moreno Pablo, Wu Yi-Lo |
| Fine-mapping markers of lung cancer susceptibility in a sub-region of chromosome 19q13.3 among Chinese. Oncotarget 2016 May . Yin Jiaoyang, Wang Huiwen, Vogel Ulla, Wang Chunhong, Ma Yegang, Hou Wei, Zhang Ying, Guo Li, Li Xinx |
| Combined analysis of rearrangement of ALK, ROS1, somatic mutation of EGFR, KRAS, BRAF, PIK3CA, and mRNA expression of ERCC1, TYMS, RRM1, TUBB3, EGFR in patients with non-small cell lung cancer and their clinical significance. Cancer chemotherapy and pharmacology 2016 Mar 77 (3): 583-93. Zhang Quan, Sun Tianyu, Kang Poming, Qian Kai, Deng Bo, Zhou Jinghai, Wang Ruwen, Jiang Bin, Li Kun, Liu Fang, Wu Shiyang, Tan Quny |
| A Significant Statistical Advancement on the Predictive Values of ERCC1 Polymorphisms for Clinical Outcomes of Platinum-Based Chemotherapy in Non-Small Cell Lung Cancer: An Updated Meta-Analysis. Disease markers 2016 2016 7643981. Han Yali, Liu Jie, Sun Meili, Zhang Zongpu, Liu Chuanyong, Sun Yupi |
| Effect of the ERCC1 (C118T) Polymorphism on Treatment Response in Advanced Non-Small Cell Lung Cancer Patients Undergoing Platinum-Based Chemotherapy Asian Pacific journal of cancer prevention : APJCP 2016 11 17 (11): 4917-4920. Kaewbubpa Walennee, Areepium Nutthada, Sriuranpong Viro |
| Functional intronic ERCC1 polymorphism from regulomeDB can predict survival in lung cancer after surgery. Oncotarget 2015 Sep 6 (27): 24522-32. Lee Shin Yup, Hong Mi Jeong, Jeon Hyo-Sung, Choi Yi Young, Choi Jin Eun, Kang Hyo-Gyoung, Jung Deuk Kju, Jin Chengcheng, Do Sook Kyung, Yoo Seung Soo, Seok Yangki, Lee Eung Bae, Shin Kyung Min, Jeong Ji Yun, Lee Won Kee, Lee Jaehee, Cha Seung Ick, Kim Chang Ho, Kim Young Tae, Jheon Sanghoon, Park Jae Yo |
| Polymorphisms in ERCC1 and ERCC2/XPD genes and carcinogen DNA adducts in human lung. Lung cancer (Amsterdam, Netherlands) 2015 Jul 89 (1): 8-12. Lee Mi-Sun, Liu Chen-yu, Su Li, Christiani David |
| The relationship between polymorphisms of genes regulating DNA repair or cell division and the toxicity of platinum and vinorelbine chemotherapy in advanced NSCLC patients. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2015 Jul . Powrózek T, Mlak R, Krawczyk P, Homa I, Ciesielka M, Kozio? P, Prendecka M, Milanowski J, Ma?ecka-Massalska |
| Prognostic value of ERCC1, ERCC2, XRCC1, and TP53 single nucleotide polymorphisms in patients with early-stage non-small cell lung cancer. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2015 Jun 36 (6): 4279-85. Geredeli Caglayan, Artac Mehmet, Yildirim Selman, Inal Ali, Dede Isa, Guler Tunc, Boruban Melih Cem, Koral Lokman, Karaagac Mustafa, Zamani Ayse Gul, Altinok Tamer, Aribas Olgun, Bozcuk Hakan, Demirkazik Ahm |
| ERCC1 SNPs as Potential Predictive Biomarkers in Non-Small Cell Lung Cancer Patients Treated With Platinum-Based Chemotherapy. Cancer investigation 2015 Apr 33 (4): 107-13. Kalikaki Aristea, Voutsina Alexandra, Koutsopoulos Anastasios, Papadaki Chara, Sfakianaki Maria, Yachnakis Emmanouel, Xyrafas Alexandros, Kotsakis Athanasios, Agelaki Sofia, Souglakos John, Mavroudis Dimitrios, Georgoulias Vassil |
| Association between epidermal growth factor receptor mutations and the expression of excision repair cross-complementing protein 1 and ribonucleotide reductase subunit M1 mRNA in patients with non-small cell lung cancer. Experimental and therapeutic medicine 2015 Mar 9 (3): 880-884. Xu Chun-Wei, Wang Gang, Wang Wu-Long, Gao Wen-Bin, Han Chuan-Jun, Gao Jing-Shan, Li Yang, Wang Lin, Zhang Li-Ying, Zhang Yu-Ping, Tian Yu-Wang, Fang Jin- |
| Polymorphisms in ERCC1 and XPF gene and response to chemotherapy and overall survival of non-small cell lung cancer. International journal of clinical and experimental pathology 2015 8 (3): 3132-7. Shi Zong-Hua, Shi Guang-Yong, Liu Lin-Ga |
| The Significant Interaction of Excision Repair Cross-complementing Group 1 Genotypes and Smoking to Lung Cancer Risk. Cancer genomics & proteomics 0 17 (5): 571-577. Chen Li-Hsiou, Shen Te-Chun, Li Chia-Hsiang, Chiu Kuo-Liang, Hsiau Yu-Chen, Wang Yun-Chi, Gong Chi-Li, Wang Zhi-Hong, Chang Wen-Shin, Tsai Chia-Wen, Hsia Te-Chun, Bau DA-Ti |
- Page last reviewed:Feb 1, 2023
- Page last updated:Feb 03, 2023
- Content source: